Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244
11 - 20 out of 57Page size: 10
Sort by: Start date
  1. 2010

  2. International Liver Cancer Association (ILCA) (External organisation)

    Andersen, Jesper Bøje (Member)

    2010

    Activity: Membership types › Membership in research network

  3. 2011

  4. Gastroenterology; Liver Transplantation; Clinical Gastroenterology & Hepatology (Journal)

    Andersen, Jesper Bøje (Review editor)

    2011

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  5. Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

    Andersen, Jesper Bøje (Speaker)

    2011

    Activity: Talk or presentation types › Lecture and oral contribution

  6. ILCA: Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

    Andersen, Jesper Bøje (Speaker)

    2011

    Activity: Talk or presentation types › Lecture and oral contribution

  7. 2012

  8. British Journal of Cancer; Journal of Cancer Therapeutics & Research, BMC Cancer; Cancer Research; Clinical Cancer Research; PLoS ONE (Journal)

    Andersen, Jesper Bøje (Review editor)

    2012

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  9. ILCA workshop: Signalling pathways and molecular therapies in liver cancer: Rationale for Targeted Therapies in Intrahepatic Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  10. ILCA: Application of Translational Genomics for Targeted Therapy in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  11. Novel Therapeutic Approaches for Treatment of Primary Liver Cancer: Epigenomic-driven therapy

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  12. The Hepatobiliary Cancers Foundation (CanLiv): Genomic Basis for Targeted Therapies in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  13. 2013

  14. AASLD: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma.: Experimental Hepatocarcinogenesis

    Andersen, Jesper Bøje (Speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

Previous 1 2 3 4 5 6 Next

ID: 93714085